Oropharyngeal resistome remains stable during COVID-19 therapy, while fecal resistome shifts toward a less diverse resistotype.
Starikova EV, Galeeva YS, Fedorov DE, Korneenko EV, Speranskaya AS, Selezneva OV, Zoruk PY, Klimina KM, Veselovsky VA, Morozov MD, Boldyreva DI, Olekhnovich EI, Manolov AI, Pavlenko AV, Kozlov IE, Yanushevich OO, Krikheli NI, Levchenko OV, Andreev DN, Sokolov FS, Fomenko AK, Devkota MK, Andreev NG, Zaborovsky AV, Tsaregorodtsev SV, Evdokimov VV, Bely PA, Maev IV, Govorun VM, Ilina EN.
Starikova EV, et al. Among authors: pavlenko av.
iScience. 2024 Nov 5;27(12):111319. doi: 10.1016/j.isci.2024.111319. eCollection 2024 Dec 20.
iScience. 2024.
PMID: 39640576
Free PMC article.